Home › Carcinoma a cellule squamose della testa e del collo › Oklahoma › Oklahoma City
Studi clinici su Carcinoma a cellule squamose della testa e del collo a Oklahoma City, OK
13 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a Oklahoma City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
In reclutamentoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
In reclutamentoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
In reclutamentoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
In reclutamentoFase 3
- Stephenson Cancer Center, Oklahoma City
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
In reclutamentoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Oklahoma City
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
In reclutamentoFase 2/3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
In reclutamentoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- SSM OKC Hightower Clinical, Oklahoma City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
In reclutamentoFase 1
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
In reclutamentoFase 1
- Dren Investigational Site, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
In reclutamentoFase 1
- University of Oklahoma, Oklahoma City
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- Nashville, TN39 studi
- New York City, NY39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Chicago, IL26 studi
- Philadelphia, PA26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- Pittsburgh, PA22 studi
Altri studi a Oklahoma City
- Cancro del polmone non a piccole cellule28 studi
- Cancro ovarico28 studi
- Cancro dell'endometrio25 studi
- Cancro colorettale22 studi
- Cancro alla prostata21 studi
- Cancro ai polmoni19 studi
- Cancro al seno17 studi
- Cancro metastatico16 studi
- Cancro (tutti i tipi)14 studi
- Leucemia mieloide acuta14 studi
- Cancro della vescica11 studi
- Cancro pancreatico11 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.